Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174881 | 0.84 | HTR1A (0.34) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL6173734 | 0.82 | HTR1A (0.33) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL7754472 | 0.82 | BCL2A1 (0.31) | BCL2A1 | |
| SCHEMBL6974485 | 0.74 | DHODH (0.37) | — | |
| SCHEMBL7101307 | 0.73 | HTR1A (0.33) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL6174842 | 0.73 | PGR (0.41) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL8672829 | 0.71 | BCAT2 (0.32) | — | |
| SCHEMBL6174205 | 0.70 | PGR (0.34) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL6699122 | 0.68 | BCAT2 (0.33) | — | |
| SCHEMBL6703631 | 0.67 | BCAT2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189893-B1 | SUBSTITUTED 2-ARYL-1,2,4-TRIAZINE-3,5-DI(THI)ONE | BAYER CROPSCIENCE AG (DE) | 2005-09-07 | — | — | EP | disclosed |
| US-6608004-B2 | Nitrogen compounds such as 2-(5-(N-phenoxy-carbonyl-N-ethyl-sulphonylamino)-4-cyano-2-fluoro-phenyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione, used as postemergence herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2003-08-19 | — | — | US | disclosed |
| US-20030069140-A1 | Substitutes 2-aryl-1,2,4-triazine-3,5-di(thi)one | BAYER AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | US | disclosed |
| EP-1189893-A2 | SUBSTITUTED 2-ARYL-1,2,4-TRIAZINE-3,5-DI(THI)ONE | Bayer Aktiengesellschaft (DE) | 2002-03-27 | — | — | EP | disclosed |
| WO-2000075119-A2 | SUBSTITUTED 2-ARYL-1,2,4-TRIAZINE-3,5-DI(THI)ONES USED AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069140-A1 | Substitutes 2-aryl-1,2,4-triazine-3,5-di(thi)one | DDT, SULT1E1, CYP1A1 | BCL2A1 728/4885HTR1A 276/4885ADRA1D 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.